KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.87 $1.65 Friday, 26th Apr 2024 ADAP stock ended at $1.08. This is 1.42% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 5.83% from a day low at $1.03 to a day high of $1.09.
90 days $0.730 $2.05
52 weeks $0.420 $2.05

Historical Adaptimmune Therapeutics plc prices

Date Open High Low Close Volume
Apr 11, 2016 $9.29 $9.29 $9.29 $9.29 94 488
Apr 08, 2016 $9.82 $9.82 $9.82 $9.82 148 426
Apr 07, 2016 $9.99 $9.99 $9.99 $9.99 307 420
Apr 06, 2016 $9.48 $9.48 $9.48 $9.48 172 026
Apr 05, 2016 $8.85 $8.85 $8.85 $8.85 153 247
Apr 04, 2016 $8.62 $8.62 $8.62 $8.62 245 487
Apr 01, 2016 $8.30 $8.30 $8.30 $8.30 124 117
Mar 31, 2016 $8.13 $8.13 $8.13 $8.13 274 836
Mar 30, 2016 $7.76 $7.76 $7.76 $7.76 304 884
Mar 29, 2016 $7.99 $7.99 $7.99 $7.99 165 200
Mar 28, 2016 $7.80 $7.80 $7.80 $7.80 123 800
Mar 24, 2016 $7.92 $7.92 $7.92 $7.92 142 500
Mar 23, 2016 $7.76 $7.76 $7.76 $7.76 211 400
Mar 22, 2016 $8.40 $8.40 $8.40 $8.40 168 000
Mar 21, 2016 $7.82 $7.82 $7.82 $7.82 154 900
Mar 18, 2016 $7.61 $7.61 $7.61 $7.61 107 700
Mar 17, 2016 $7.53 $7.53 $7.53 $7.53 165 500
Mar 16, 2016 $7.91 $7.91 $7.91 $7.91 134 600
Mar 15, 2016 $7.87 $7.87 $7.87 $7.87 237 000
Mar 14, 2016 $8.13 $8.13 $8.13 $8.13 295 300
Mar 11, 2016 $8.23 $8.23 $8.23 $8.23 303 700
Mar 10, 2016 $7.76 $7.76 $7.76 $7.76 221 500
Mar 09, 2016 $8.34 $8.34 $8.34 $8.34 314 000
Mar 08, 2016 $8.92 $8.92 $8.92 $8.92 329 100
Mar 07, 2016 $9.06 $9.06 $9.06 $9.06 297 500
Click to get the best stock tips daily for free!

About Adaptimmune Therapeutics plc

Adaptimmune Therapeutics plc Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4 that is in phase II clinical trials with SPEARHEAD-1 for synovial sarcoma and myxoid round cell liposa... ADAP Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT